SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.250
0.00 (0.00%)
At close: Nov 3, 2025, 4:00 PM EST
3.240
-0.010 (-0.31%)
After-hours: Nov 3, 2025, 6:03 PM EST
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $33.84 million as of November 3, 2025. Its market cap has increased by 17.88% in one year.
Market Cap
33.84M
Enterprise Value
33.24M
1-Year Change
17.88%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $33.84M, a decrease of -74.12%. That is a compound annual growth rate of -24.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 33.84M | -3.37% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |